CytoMed Therapeutics receives Nasdaq minimum bid shortfall notice
CytoMed Therapeutics Limited (GDTC) announced it received a Nasdaq notification regarding a minimum bid price deficiency.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.